Positive and negative outcomes of L-arginine therapy in cardiovascular diseases
Herbaczyńska-Cedro, K.
Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 50(4): 653-660
1999
ISSN/ISBN: 0867-5910 PMID: 10639015 Document Number: 501991
The author reviews controlled clinical investigation on the effectiveness of L-arginine in cardiovascular diseases. Positive results were observed in hyperlipidemic subjects and in patients with a critical stage of the peripheral arterial occlusive disease. Patients with stable ischemic heart disease responded to L-arginine to some extent, while results of L-arginine therapy in congestive heart failure are inconsistent. Null effects if L-arginine has been documented in essential hypertension.
Document emailed within 1 workday
Related Documents
Spits, H.; Cupp, J.; Wrighton, N.; Lee, F.; Hori, T. 1991: Human cd3 negative cd4 negative cd8 negative thymocytes differentiate into cd3 positive cd4 positive cd8 alpha positive beta positive cells in vitro in the presence of il 7 Journal of Cellular Biochemistry Suppl (15 Part F): 59Vladymyrov, O.A.; Tofan, N.I. 2003: Role of the L-arginine-NO system in the prevention and treatment of cardiovascular diseases in pregnant women Fiziolohichnyi Zhurnal 49(2): 73-78
Moraleda, C.; de Deus, N.; Serna-Bolea, C.; Renom, M.; Quintó, L.ç; Macete, E.; Menéndez, C.; Naniche, D. 2014: Impact of HIV exposure on health outcomes in HIV-negative infants born to HIV-positive mothers in Sub-Saharan Africa Journal of Acquired Immune Deficiency Syndromes 65(2): 182-189
Leshchinskiĭ, L.A.; Ponomarev, S.B.; Logacheva, I.V.; Tiul'kina, E.E.; Rusiak, I.G.; Farkhutdinov, A.F.; Mul'tanovskiĭ, B.L.; Sufiianov, V.G.; Petrov, A.G.; Dimov, A.S.; Starodubtsev, I.B. 2000: Application of high information technologies in predicting outcomes of cardiovascular diseases Klinicheskaia Meditsina 78(1): 31-33
Hino, K.; Murakami, C.; Fujii, K.; Okazaki, M.; Okuda, M.; Hanada, H.; Okita, K. 1995: Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 949-953
Chibanda, D.; Shetty, A.K.; Tshimanga, M.; Woelk, G.; Stranix-Chibanda, L.; Rusakaniko, S. 2014: Group problem-solving therapy for postnatal depression among HIV-positive and HIV-negative mothers in Zimbabwe Journal of the International Association of Providers of Aids Care 13(4): 335-341
Baharestani, M.Mylene. 2007: Use of negative pressure wound therapy in the treatment of neonatal and pediatric wounds: a retrospective examination of clinical outcomes Ostomy/Wound Management 53(6): 75-85
Dobrovic, A.; Morley, A.A.; Seshadri, R.; Januszewicz, E.H. 1991: Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML Leukemia 5(3): 187-190
Ciammella, M.; Guareschi, B.; Pes, S.; Cocucci, C.; Nencioni, T. 1993: Substitution estrogen therapy in the prevention of postmenopausal osteoporosis and cardiovascular diseases. Results of long-term therapy Minerva Ginecologica 45(1-2): 53-55
Anderson, K.; Muloiwa, R.; Davies, M.-A. 2018: Treatment outcomes in perinatally infected HIV-positive adolescents and young adults after ≥10 years on antiretroviral therapy South African Medical Journal 109(1): 27-34
McClelland, L.; Wanje, G.; Kashonga, F.; Kibe, L.; McClelland, R.S.; Kiarie, J.; Mandaliya, K.; Peshu, N.; Kurth, A. 2011: Understanding the context of HIV risk behavior among HIV-positive and HIV-negative female sex workers and male bar clients following antiretroviral therapy rollout in Mombasa, Kenya Aids Education and Prevention: Official Publication of the International Society for Aids Education 23(4): 299-312
Boone, D.; Braitman, E.; Gentics, C.; Afthinos, J.; Latif, J.; Sordillo, E.; Todd, G.; Lantis Ii, J.C. 2010: Bacterial burden and wound outcomes as influenced by negative pressure wound therapy Wounds: a Compendium of Clinical Research and Practice 22(2): 32-37
Viravaidya, M.; Wolf, R.C.; Guest, P. 2008: An assessment of the positive partnership project in Thailand: key considerations for scaling-up microcredit loans for HIV-positive and negative pairs in other settings Global Public Health 3(2): 115-136
Weser, C.; Klessen, D. 1978: Strategy for the control of cardiovascular diseases in a metropolis (demonstrated by the Berlin concept of a unified system of care for patients with cardiovascular diseases) Zeitschrift für Arztliche Fortbildung 72(20): 967-971
Taradiĭ, N.N.; Bagdasarova, I.V.; Uzdenova, Z.K.; Bichekueva, F.K.; Doloman, L.B.; Kotsiuruba, A.V.; Krivokhatskaia, L.D.; Kamenetskaia, O.V.; Mandziuk, I.P.; Volkova, L.N. 2003: Expression of markers of immunocompetent cells, cytokine level, and L-arginine metabolism in complex extremely high frequency and interferon therapy of inflammatory diseases in women of highlands Fiziolohichnyi Zhurnal 49(3): 80-89
Thiele, D.L.; DuCharme, L.; Cunningham, M.R.; Mimms, L.T.; Cuthbert, J.A.; Lee, W.M.; Combes, B. 1996: Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients American Journal of Gastroenterology 91(2): 300-308
Bassuk, S.S.; Manson, J.E. 2015: Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes Annals of Epidemiology 25(3): 193-200
Conradi, E. 1972: Exercise therapy in cardiovascular diseases Zeitschrift für Arztliche Fortbildung 66(9): 462-466
Attramadal, H.; Berg, K. 2001: Gene therapy in cardiovascular diseases Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(4): 489-491
Striffeler, H.; Kipfer, B.; Althaus, U.; Carrel, T. 1997: Homograft in the therapy of cardiovascular diseases Praxis 86(12): 476-481